The effect of COVID-19 on development of hair and nail disorders: a Turkish multicenter, controlled study

Basit Öğe Kaydı
dc.authorid-en_US
dc.authorscopusid56924708500en_US
dc.authorwosidAAK-4705-2020en_US
dc.contributor.authorKutlu, Ömer
dc.contributor.authorTaş Demircan, Yuhanize
dc.contributor.authorYıldız, Kenan
dc.contributor.authorKalkan, Göknur
dc.contributor.authorDemirseren, Duriye Deniz
dc.contributor.authorAn, İsa
dc.contributor.authorOba, Muazzez Çiğdem
dc.contributor.authorKılıç, Sevilay
dc.date.accessioned2024-01-24T08:21:27Z
dc.date.available2024-01-24T08:21:27Z
dc.date.issued2023en_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
dc.description.abstractBackground: A broad spectrum of skin diseases, including hair and nails, can be directly or indirectly triggered by COVID-19. It is aimed to examine the type and frequency of hair and nail disorders after COVID-19 infection. Methods: This is a multicenter study conducted on consecutive 2171 post-COVID-19 patients. Patients who developed hair and nail disorders and did not develop hair and nail disorders were recruited as subject and control groups. The type and frequency of hair and nail disorders were examined. Results: The rate of the previous admission in hospital due to COVID-19 was statistically significantly more common in patients who developed hair loss after getting infected with COVID-19 (P < 0.001). Telogen effluvium (85%) was the most common hair loss type followed by worsening of androgenetic alopecia (7%) after COVID-19 infection. The mean stress scores during and after getting infected with COVID-19 were 6.88 ± 2.77 and 3.64 ± 3.04, respectively, in the hair loss group and were 5.77 ± 3.18 and 2.81 ± 2.84, respectively, in the control group (P < 0.001, P < 0.001). The frequency of recurrent COVID-19 was statistically significantly higher in men with severe androgenetic alopecia (Grades 4–7 HNS) (P = 0.012; Odds ratio: 2.931 [1.222–7.027]). The most common nail disorders were leukonychia, onycholysis, Beau's lines, onychomadesis, and onychoschisis, respectively. The symptoms of COVID-19 were statistically significantly more common in patients having nail disorders after getting infected with COVID-19 when compared to the control group (P < 0.05). Conclusion: The development of both nail and hair disorders after COVID-19 seems to be related to a history of severe COVID-19.en_US
dc.identifier.citationKutlu, Ö., Demircan, Y. T., Yıldız, K., Kalkan, G., Demirseren, D. D., An, İ., … Karadağ, A. S. (2023). The effect of COVID‐19 on development of hair and nail disorders: a Turkish multicenter, controlled study. International Journal of Dermatology, 62(2), 202–211. https://doi.org/10.1111/ijd.16454en_US
dc.identifier.doi10.1111/ijd.16454
dc.identifier.endpage211en_US
dc.identifier.issn0011-9059
dc.identifier.issn1365-4632
dc.identifier.issue2en_US
dc.identifier.pmid36281828
dc.identifier.scopus2-s2.0-85140408930
dc.identifier.startpage202en_US
dc.identifier.urihttps://doi.org/10.1111/ijd.16454
dc.identifier.urihttps://hdl.handle.net/20.500.12428/5373
dc.identifier.volume62en_US
dc.identifier.wosWOS:000871413000001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorKılıç, Sevilay
dc.language.isoen
dc.publisherJohn Wiley and Sons Incen_US
dc.relation.ispartofInternational Journal of Dermatologyen_US
dc.relation.publicationcategoryRaporen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAlopeciaen_US
dc.subjectAlopecia Areataen_US
dc.subjectCOVID-19en_US
dc.subjectHairen_US
dc.subjectHumansen_US
dc.subjectMaleen_US
dc.subjectNail Diseasesen_US
dc.subjectNailsen_US
dc.subjectNails, Malformeden_US
dc.titleThe effect of COVID-19 on development of hair and nail disorders: a Turkish multicenter, controlled study
dc.typeReport

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
Sevilay_Kilic_Report.pdf
Boyut:
564.13 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Report
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu